|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/21 | |
| C07K 19/00 | |||
| A61K 38/16 | |||
| C07K 14/195 |
| (11) | Number of the document | 3006457 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15191391.0 |
| Date of filing the European patent application | 2006-07-25 | |
| (97) | Date of publication of the European application | 2016-04-13 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-22 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 703798 P | 2005-07-29 | US |
| (72) |
PASTAN, Ira, H., US
ONDA, Masanori, US
NAGATA, Satoshi, US
FITZGERALD, David, US
KREITMAN, Robert, US
LEE, Byungkook, US
|
| (73) |
The Government of the United States of America, as represented by the Secretary of Health and Human Services,
National Institutes of Health Office of Technology Transfer 6011 Executive Boulevard Suite 325, Rockville, MD 20852-3804,
US
|
| (54) | MUTATED PSEUDOMONAS EXOTOXINS WITH REDUCED ANTIGENICITY |
| MUTATED PSEUDOMONAS EXOTOXINS WITH REDUCED ANTIGENICITY |